Have you even read this paper you illiterate blind bat??? Steroids are the first line treatment. ACE inhibitors are recommended for use but not the standard of care. I don't even know why I am replying to you and wasting my time.
I trust you stay friends with that nephrologist mate of yours after this stock takes off.
read this and weep:
30 publications were selected; 5 were controlled trials (4 randomized controlled trials). 8 assessed RAAS inhibitor monotherapy, while the rest studied RAAS inhibitors in combination with other drugs, mainly immunosuppressants. On average, a 32% proteinuria reduction (ROM, 0.68; 95% CI, 0.47-0.98) and no change in creatinine clearance (ROM, 0.95; 95% CI, 0.77-1.16) from baseline to the last reported follow-up was observed in patients treated with RAAS inhibitor monotherapy. When a RAAS inhibitor was combined with other drugs, a 72% proteinuria reduction was observed from baseline to the last reported follow-up (ROM, 0.24; 95% CI, 0.08-0.75). The published data did not allow for the assessment of the effects of RAAS inhibitor monotherapy on estimated glomerular filtration rate and end-stage kidney disease risks.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065901/
Have you even read this paper you illiterate blind bat???...
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.015(4.17%) |
Mkt cap ! $189.6M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.0¢ | 34.5¢ | $1.017M | 2.870M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 105388 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 90744 | 7 |
View Market Depth
| Last trade - 11.47am 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
34.5¢ |
Change
-0.015 ( 4.14 %) |
||||
| Open | High | Low | Volume | ||
| 36.5¢ | 37.0¢ | 34.0¢ | 1373742 | ||
| Last updated 12.06pm 06/05/2024 ? | |||||
| DXB (ASX) Chart |